TECNOTREE
26.2.2024 11:51:29 CET | Business Wire | Press release
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies announced being awarded a new multimillion-dollar deal with Umniah, a leading provider of a range of telecom solutions in the MENA region with up to 3 million subscribers. With this project, Tecnotree aims to provide AI-embedded BSS customer engagement for the operator. The deal, implementing a full BSS stack along with the Tecnotree Sensa Intelligence platform operationalizes AI across business workflows and is the second win for Tecnotree in terms of AIML-driven customer experience use case.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240226721394/en/
Tecnotree Secures Multimillion-Dollar Deal with Umniah, Pioneering Sensa AIML Embedded BSS Transformation (Photo: Business Wire)
Under this project, Umniah seeks to upgrade its current CRM system with a new CX implementation targeting improvements in NPS, reduction of churn, and an increase in ARPU. As part of the agreement, Tecnotree will deploy Sensa AI-embedded BSS applications streamlining the AI development lifecycle and driving faster time to value across products.
The applications will include a dynamic bundle of product catalogues, digital self-care and customer management, catalogue-driven order management, demand generation through omnichannel campaigns and configurable integration with leading social networks, lead and funnel management, enterprise workforce management with business process orchestration, business intelligence, and analytics capabilities, enterprise and consumer service request management, partner management, E-Shop (marketplace) & B2B self-care portal. The solution will provide the operator with a unified solution with embedded intelligence for transformation across all applications, that enables B2B2X cross-sell and up-sell capabilities.
Faisal Qamhiyah, CEO of Umniah, stated, “Launching the advanced Customer Experience (CX) platform marks a pivotal step in our transformation to revolutionize customer interactions and fulfill their digital age expectations. It demonstrates our dedication to comprehending our customers, engaging with them, and keeping them informed about the digital world's evolving landscape. With customer expectations for seamless, personalized experiences at an all-time high, this platform aims to surpass these demands by providing an in-depth perspective of customer interactions.”
Qamhiyah added, “Umniah envisions a future where its corporate clients excel in understanding and meeting their customers' dynamic needs, driving them towards sustainable growth and success in the digital age.”
Commenting on the new deal, Padma Ravichander, CEO of Tecnotree Corporation, said, “We are very excited to embark on this new chapter with Umniah, as we help them redefine unparalleled digital experiences with the help of our Digital BSS and Sensa AIML fabric, for their business transformation. Our digital BSS stack embedded with Tecnotree Sensa AIML capabilities will enable the customer to improve business agility and respond faster to market dynamics while humanizing experiences and empowering customer journey lifecycle with Sensa hyper-personalisation.”
The transformation will also enable them to optimize operational costs, while significantly improving revenue monetization capability with our AI/ML-based insights and recommendations. The collaboration marks a significant stride for Tecnotree in the field of artificial intelligence, reinforcing our commitment to enhance digital services that create business differentiation and help our customers deliver second-to-none customer experiences”
About Tecnotree
Tecnotree is a 5G-ready digital Business Support System (BSS) player, with AI/ML capabilities and multi-cloud extensibility. Tecnotree leads the way on the TM Forum Open API Conformance with 59 certified Open APIs including 9 real-world open APIs, a testament to the company's commitment to excellence, and continuously striving to deliver differentiated experiences and services to both CSPs and DSPs. Our agile and open-source digital BSS Stack comprises the full range (order-to-cash) of business processes and subscription management for telecom and other digital services industries creating opportunities beyond connectivity. Tecnotree also provides Fintech and B2B2X multi-experience digital marketplace to its subscriber base through the Tecnotree Moments platform to empower digitally connected communities across gaming, health, education, OTT, and other vertical ecosystems. Tecnotree is listed on the Helsinki Nasdaq (TEM1V).
About Umniah
Since its launch in 2005, Umniah, a subsidiary of Beyon Group, has been recognized as one the fastest growing and reliable telecommunications providers in the region’s most competitive markets, offering a wide variety of transformative high-quality mobile, Internet, and enterprise solutions. The award-winning company champions innovation, digital transformation, and technological advancement, delivering to its 3 million subscribers reliability and connectivity through an inclusive range of products and solutions that meet distinctive individual and corporate needs. The company also has a comprehensive and effective sustainability strategy that outlines its environmental, social, and corporate governance practices as well as its commitment to making positive changes in the lives of individuals and society.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240226721394/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom